FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

  
gfedcb

If this is a report of a second or subsequent transplant, check here and continue with question 31

 
 
1  What was the date of diagnosis of Aplastic Anemia? __ __ __ __ - __ __- __ __  

 
 

2  Was the recipient's bone marrow examined at diagnosis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

3  Is a copy of the biopsy report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

4  Were the recipient's cells tested for sensitivity to cross-linking agents (e.g., diepoxybutane (DEB), mitomycin C (MMC))?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

5  Specify the test results:

    
 nmlkji

Normal  

 nmlkji
increased chromosome breaks  

 nmlkji
Unknown  

 
 

6  Is a copy of the test report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

7  What was the disease etiology?

    
 nmlkji

Diamond-Blackfan anemia  

 nmlkji
drug induced  

 nmlkji
viral hepatitis  

 nmlkji
idiopathic  

 nmlkji
Other  

  Key Fields 

Disease Assessment at Diagnosis Questions: 1 - 18

Form 2028 R2.0: Aplastic Anemia Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2028 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 4



  
 
8  Specify drug:    

 
  

gfedcb
drug unknown

  
 
9  Specify type:    

 
  

gfedcb
type unknown

  
 
10  Specify disease etiology:    

 
  

gfedcb
etiology unknown

 
 

11  Was testing for paroxysmal nocturnal hemoglobinuria (PNH) performed?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify PNH test and results: 
 

12  Flow cytometry for CD55 / CD16 / CD59

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Unknown  

 
 

13  Ham's acid hemolysis test

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Unknown  

 
 

14  Hemosiderinuria

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Unknown  

 
 

15  PIGA GPI anchor protein defect

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Unknown  

 
 

16  Sugar water / sucrose lysis test

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Unknown  

 
 

17  Other test

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Unknown  

 
 
18  Specify test:    

 

Report findings prior to any first treatment for aplastic anemia. 
 

19  WBC:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
20     

 

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

21  Hemoglobin (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
22     

 

 nmlkji
g/dL  

 nmlkji
g/L  

 nmlkji
mmol/L  

 
 

23  Was RBC transfused < 30 days before date of test?

    
 nmlkji

yes  
 nmlkji

no  

 
 

24  Platelets (untransfused):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
25     

 

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

26  Were platelets transfused < 7 days before date of test?

    
 nmlkji

yes  
 nmlkji

no  

  Laboratory Studies at Diagnosis Questions: 19 - 49

Form 2028 R2.0: Aplastic Anemia Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2028 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 4



 
 

27  Neutrophils:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
28     109/L 

 
 

29  Reticulocytes (uncorrected):

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
30     109/L 

 
 

31  Was therapy given for treatment of aplastic anemia prior to the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify what treatment(s) were given: 
 

32  Androgens

    
 nmlkji

yes  
 nmlkji

no  

 
 

33  ATG, ALS, ATS, ALG

    
 nmlkji

yes  
 nmlkji

no  

 
 

34  Chelation therapy for iron

    
 nmlkji

yes  
 nmlkji

no  

 
 

35  Corticosteroids

    
 nmlkji

yes  
 nmlkji

no  

 
 

36  Cyclosporine (CsA, Neoral, Sandimmune)

    
 nmlkji

yes  
 nmlkji

no  

 
 

37  Cytokines

    
 nmlkji

yes  
 nmlkji

no  

 

If yes, specify cytokine(s) given: 
 

38  Erythropoietin (EPO)

    
 nmlkji

yes  
 nmlkji

no  

 
 

39  G-CSF (filgrastim, Neupogen)

    
 nmlkji

yes  
 nmlkji

no  

 
 

40  GM-CSF (sargramostim, Leukine)

    
 nmlkji

yes  
 nmlkji

no  

 
 

41  Interleukin-3 (IL-3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

42  Pegfilgrastim (Neulasta)

    
 nmlkji

yes  
 nmlkji

no  

 
 

43  Stem cell factor (SCF)

    
 nmlkji

yes  
 nmlkji

no  

 
 

44  Other

    
 nmlkji

yes  
 nmlkji

no  

 
 
45  Specify other cytokine:    

 
 

46  Other immunosuppression

    
 nmlkji

yes  
 nmlkji

no  

 
 
47  Specify immunosuppression:    

Form 2028 R2.0: Aplastic Anemia Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2028 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 4



 
 

48  Other treatment

    
 nmlkji

yes  
 nmlkji

no  

 
 
49  If yes, specify treatment:    

 
 

50  Did the recipient receive red blood cell transfusions between diagnosis and the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 
 

51  Specify the total number of donor exposures (best estimate):

    
 nmlkji

1-5  
 nmlkji

6-10  
 nmlkji

11-20  
 nmlkji

21-30  
 nmlkji

31-40  
 nmlkji

41-50  
 nmlkji

>=51  
 nmlkji

Unknown  

 
 

52  Did the recipient receive platelet transfusions between diagnosis and the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 
 

53  Reticulocytes (uncorrected):

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
54     109/L 

 
 
55  Date of most recent bone marrow biopsy: __ __ __ __ - __ __- __ __  

 
 

56  Is a copy of the most recent bone marrow biopsy report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

57  Were any clinically important infections present or being treated within one week prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Report each infection organism, site and date of diagnosis.  
 
58  Organism:   

 
59  If other, 

specify:
   

    The codes for "other organism, specify" (codes 198, 209, 219, 259, 329, and 409) should rarely be needed; check with your microbiology lab or HSCT 
physician before using them.   

 
 

60  Site:   

    Do not report fever in the absence of infection.  Report the most specific site of infection. 

 
 
61  Date of diagnosis: __ __ __ __ - __ __- __ __  

  
 
First Name:    

 
Last Name:    

  
 
Phone:    

 
Fax number:    

 
 
E-mail address:    

  Transfusion Status from Diagnosis to the Start of the Preparative Regimen Questions: 50 - 52

  Laboratory Findings Prior to the Start of the Preparative Regimen Questions: 53 - 61

  Infection(s) (1) Questions: 58 - 61 

Form 2028 R2.0: Aplastic Anemia Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2028 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 4